Clinical and pharmacological evaluation of cephapirin sodium (BL-P-1322) in infants and children (cephapirin in pediatric patients).
D001219:Aspartate Aminotransferases / Q000097:blood; D001419:Bacteria / Q000187:drug effects; D001424:Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D002511:Cephalosporins / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use* / Q000652:urine; D002648:Child; D002675:Child, Preschool; D004305:Dose-Response Relationship, Drug; D004802:Eosinophilia / Q000139:chemically induced; D006192:Haemophilus Infections / Q000188:drug therapy; D006193:Haemophilus influenzae / Q000187:drug effects; D006801:Humans; D007223:Infant; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D011014:Pneumonia / Q000188:drug therapy / Q000382:microbiology
D002511:Cephalosporins; D001219:Aspartate Aminotransferases